Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Retraction: Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors.

Hayakawa Y, Berzins SP, Crowe NY, Godfrey DI, Smyth MJ.

Nat Immunol. 2006 Aug;7(8):890. No abstract available.

PMID:
16855608
2.

Differential antitumor immunity mediated by NKT cell subsets in vivo.

Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG, Hayakawa Y, Godfrey DI, Smyth MJ.

J Exp Med. 2005 Nov 7;202(9):1279-88.

3.

NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.

Uldrich AP, Crowe NY, Kyparissoudis K, Pellicci DG, Zhan Y, Lew AM, Bouillet P, Strasser A, Smyth MJ, Godfrey DI.

J Immunol. 2005 Sep 1;175(5):3092-3101.

4.

Regulation of antitumour immunity by CD1d-restricted NKT cells.

Swann J, Crowe NY, Hayakawa Y, Godfrey DI, Smyth MJ.

Immunol Cell Biol. 2004 Jun;82(3):323-31. Review.

PMID:
15186264
5.

Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors.

Hayakawa Y, Berzins SP, Crowe NY, Godfrey DI, Smyth MJ.

Nat Immunol. 2004 Jun;5(6):590-6. Epub 2004 May 2. Retraction in: Hayakawa Y, Berzins SP, Crowe NY, Godfrey DI, Smyth MJ. Nat Immunol. 2006 Aug;7(8):890.

PMID:
15122252
6.

Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells.

Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJ, Hayakawa Y, Sidobre S, Keating R, Kronenberg M, Smyth MJ, Godfrey DI.

J Immunol. 2003 Oct 15;171(8):4020-7.

7.

Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide.

Pellicci DG, Uldrich AP, Kyparissoudis K, Crowe NY, Brooks AG, Hammond KJ, Sidobre S, Kronenberg M, Smyth MJ, Godfrey DI.

Eur J Immunol. 2003 Jul;33(7):1816-23.

8.

Natural killer T cells are targets for human immunodeficiency virus infection.

Crowe NY, Godfrey DI, Baxter AG.

Immunology. 2003 Jan;108(1):1-2. No abstract available.

9.
10.

NKT cells - conductors of tumor immunity?

Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI.

Curr Opin Immunol. 2002 Apr;14(2):165-71. Review.

PMID:
11869887
11.

Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.

Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI.

Blood. 2002 Feb 15;99(4):1259-66.

12.

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

Smyth MJ, Crowe NY, Godfrey DI.

Int Immunol. 2001 Apr;13(4):459-63.

PMID:
11282985
13.

Differential tumor surveillance by natural killer (NK) and NKT cells.

Smyth MJ, Thia KY, Street SE, Cretney E, Trapani JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI.

J Exp Med. 2000 Feb 21;191(4):661-8.

14.

NKT cells are phenotypically and functionally diverse.

Hammond KJ, Pelikan SB, Crowe NY, Randle-Barrett E, Nakayama T, Taniguchi M, Smyth MJ, van Driel IR, Scollay R, Baxter AG, Godfrey DI.

Eur J Immunol. 1999 Nov;29(11):3768-81.

Supplemental Content

Loading ...
Support Center